Biology Reference
In-Depth Information
Dobbelaere, D.A., Fernandez, P.C., Heussler,V.T., 2000.
Theileria parva
: taking control of host
cell proliferation and survival mechanisms. Cell. Microbiol. 2, 91-99.
Donaldson, T., Kim, K., 2010. Targeting
Plasmodium falciparum
purine salvage enzymes: a look
at structure-based drug development. Infect. Disord. Drug Targets. 10, 191-199.
Dow, G., Bauman, R., Caridha, D., Cabezas, M., Du, F., Gomez-Lobo, R., Park, M., Smith,
K., Cannard, K., 2006. Mefloquine induces dose-related neurological effects in a rat
model. Antimicrob. Agents Chemother. 50, 1045-1053.
Driscoll, M., Dean, E., Reilly, E., Bergholz, E., Chalfie, M., 1989. Genetic and molecular
analysis of a
Caenorhabditis elegans
beta-tubulin that conveys benzimidazole sensitivity.
J. Cell. Biol. 109, 2993-3003.
Duffy, S., Avery, V.M., 2012. Development and optimization of a novel 384-well anti-
malarial imaging assay validated for high-throughput screening. Am. J. Trop. Med. Hyg.
86, 84-92.
Dzierszinski, F., Popescu, O., Toursel, C., Slomianny, C., Yahiaoui, B., Tomavo, S., 1999. The
protozoan parasite
Toxoplasma gondii
expresses two functional plant-like glycolytic
enzymes. Implications for evolutionary origin of apicomplexans. J. Biol. Chem. 274,
24888-24895.
Edlind,T.D., 1989. Susceptibility of
Giardia lamblia
to aminoglycoside protein synthesis inhib-
itors: correlation with rRNA structure. Antimicrob. Agents Chemother. 33, 484-488.
Egan, T.J., Kaschula, C.H., 2007. Strategies to reverse drug resistance in malaria. Curr. Opin.
Infect. Dis. 20, 598-604.
Egner, U., Krätzschmar, J., Kreft, B., Pohlenz, H.D., Schneider, M., 2005. The target discovery
process. Chembiochem 6, 468-479.
Esposito, M., Müller, N., Hemphill, A., 2007. Structure-activity relationships from in vitro
efficacies of the thiazolide series against the intracellular apicomplexan protozoan
Neos-
pora caninum
. Int. J. Parasitol. 37, 183-190.
Esposito, M., Stettler, R., Moores, S.L., Pidathala, C., Müller, N., Stachulski, A., Berry, N.G.,
Rossignol, J.F., Hemphill, A., 2005. In vitro efficacies of nitazoxanide and other thia-
zolides against
Neospora caninum
tachyzoites reveal antiparasitic activity independent of
the nitro group. Antimicrob. Agents Chemother. 49, 3715-3723.
Feistel, T., Hodson, C.A., Peyton, D.H., Landfear, S.M., 2008. An expression system to screen
for inhibitors of parasite glucose transporters. Mol. Biochem. Parasitol. 162, 71-76.
Fichera, M.E., Roos, D.S., 1997. A plastid organelle as a drug target in apicomplexan para-
sites. Nature 390, 407-409.
Firman, K., Evans, L., Youell, J., 2012. A Synthetic Biology Project - developing a single-
molecule device for screening drug-target interactions. FEBS Lett. 586, 2157-2163.
Fleige, T., Soldati-Favre, D., 2008. Targeting the transcriptional and translational machinery
of the endosymbiotic organelle in apicomplexans. Curr. Drug Targets 9, 948-956.
Foley, M., Tilley, L., 1998. Quinoline antimalarials: mechanisms of action and resistance and
prospects for new agents. Pharmacol. Ther. 79, 55-87.
Franke-Fayard, B., Djokovic, D., Dooren, M.W., Ramesar, J., Waters, A.P., Falade, M.O.,
Kranendonk, M., Martinelli, A., Cravo, P., Janse, C.J., 2008. Simple and sensitive antima-
larial drug screening in vitro and in vivo using transgenic luciferase expressing
Plasmo-
dium berghei
parasites. Int. J. Parasitol. 38, 1651-1662.
Gaji, R.Y., Zhang, D., Breathnach, C.C., Vaishnava, S., Striepen, B., Howe, D.K., 2006.
Molecular genetic transfection of the coccidian parasite
Sarcocystis neurona
. Mol. Bio-
chem. Parasitol. 150, 1-9.
Gardner, T.B., Hill, D.R., 2001. Treatment of giardiasis. Clin. Microbiol. Rev. 14, 114-128.
Gargala, G., Le Goff, L., Ballet, J.J., Favennec, L., Stachulski, A.V., Rossignol, J.F., 2010. Evalua-
tion of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy
against in vitro development of
Cryptosporidium parvum
. Antimicrob. Agents Chemother.
54, 1315-1318.
Search WWH ::
Custom Search